SLC7A9 and cystic fibrosis: Eight participants (0.93%) had a carrier status and heterozygous P/LP variants for AR diseases: CFTR cystic fibrosis (5), ITGB4 junctional epidermolysis bullosa type 5A (1), MEFV AR familial Mediterranean fever (1), and SLC7A9 AR cystinuria (1) (Table S1).